Prs46 - Informing the Pathway of Copd Treatment (Impact Study) - Single Inhaler Triple Therapy (Ff/Umec/Vi) Versus Ff/Vi in Patients With Copd: Cost-Effectiveness Analysis From a Societal Perspective in Quebec
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2440
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV